MYOK MyoKardia, Inc.

12.90
-1  -5%
Previous Close 13.55
Open 13.55
Price To book 2.93
Market Cap 405.27M
Shares 31,416,000
Volume 108,787
Short Ratio 11.75
Av. Daily Volume 114,008

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 dosing initiated November 2016. Top-line data due 3Q 2017.
MYK-461 - PIONEER-HCM
Hypertrophic cardiomyopathy (HCM)

Latest News

  1. MyoKardia, Inc. – Value Analysis (NASDAQ:MYOK) : April 26, 2017
  2. MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : April 25, 2017
  3. MyoKardia Appoints David Meeker, M.D., to Board of Directors
  4. ETFs with exposure to MyoKardia, Inc. : April 13, 2017
  5. MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : April 6, 2017
  6. MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017
  7. MyoKardia Appoints Kim Popovits and Wendy Yarno to Board of Directors
  8. MyoKardia reports 4Q loss
  9. MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress
  10. MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : March 10, 2017
  11. 7 Stocks Trending With Monster Volume
  12. MyoKardia to Present at Cowen and Company 37th Annual Health Care Conference
  13. MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : February 17, 2017
  14. First Subjects Dosed in Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491
  15. MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs
  16. ETFs with exposure to MyoKardia, Inc. : December 12, 2016
  17. Blog Coverage MyoKardia Announced Receipt of Payment from Sanofi